07.11.16
Thin Film Electronics ASA (Thinfilm) has entered into an agreement with a Fortune 500 pharmaceutical firm to create an NFC OpenSense platform for medical devices.
The partners will leverage Thinfilm’s proprietary NFC technology as a means to improve patient adherence and enhance communication between patients and their caregivers.
“Lack of compliance among patients is a critical issue globally, and industry leaders are looking for effective solutions,” said Davor Sutija, Thinfilm’s CEO. “Our partnership with one of the world’s leading pharma companies is focused on delivering such a solution by making medical devices smart.”
The partners will leverage Thinfilm’s proprietary NFC technology as a means to improve patient adherence and enhance communication between patients and their caregivers.
“Lack of compliance among patients is a critical issue globally, and industry leaders are looking for effective solutions,” said Davor Sutija, Thinfilm’s CEO. “Our partnership with one of the world’s leading pharma companies is focused on delivering such a solution by making medical devices smart.”